ionispharma.com (IONS): O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Ionis Pharmaceuticals (IONS) noyob patologiyalarga qarshi kurashish uchun innovatsion antisense RNA terapiyasi ekotizimini ishlab chiqmoqda. Genetika sohasidagi kashshoflik maqomi kompaniyaga o'z patentlarini litsenziyalash orqali sezarli royalti to'lovlarini shakllantirish imkonini beradi. Biznesning kengayish imkoniyati distribyutsiya xarajatlarining yo'qligi bilan ta'minlanadi. peg_co metrikasini tahlil qilib, 0.00 darajasi uning o'sish potentsialining joriy bozor qiymatini ifodalashi aniq ko'rinmoqda.
Ionis Pharmaceuticals (IONS) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
- kompaniyaning balans qiymati tafsilotlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Barcha qarzlarning o‘z mablag‘lariga nisbati Ionis Pharmaceuticals|IONS - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati ionispharma.com|IONS - Kompaniya qarzlari|Qarzning sof aktivlarga nisbati Ionis Pharma|IONS - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli majburiyatlari Ionis|Tezkor likvidlik koeffitsiyenti ionispharma.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
IONS - Sof foyda|Kelajakdagi foyda Ionis Pharmaceuticals|IONS - P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Isis Pharmaceuticals|IONS - Narx-foyda va o‘sish multiplikatori|EV/EBITDA multiplikatori Ionis Pharma|IONS - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi to'rtta chorak uchun bir aksiya uchun foyda Ionis|IONS - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi ionispharma.com|IONS - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Ionis Pharmaceuticals
Kompaniyaning fundamental tahlili:Ionis Pharmaceuticals, Inc., IONS
PEG koeffitsiyenti joriy P/E bozor ko'paytirgichini foyda o'sish sur'atlari bilan solishtiradi, bu esa investorlarga kelajakdagi biznes kengayishi uchun haddan tashqari ko'p to'layotganlarini aniqlash imkonini beradi. Normallashtirilgan PEG ko'paytirgichini tahlil qilish orqali, Ionis Pharmaceuticals (IONS) kompaniyasining bozor kapitalizatsiyasiga nisbatan, nufuzli olimlarni saqlab qolish va o'zining noyob RNA platformasini ishlab chiqishga yo'naltirgan ulkan xarajatlarining samaradorligini baholash mumkin.
Ionis Pharmaceuticals raqobatchilari
O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Tempus AI, Inc|Narxning foydaga va o‘sish sur’atiga nisbati Qiagen Group QGEN|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Repligen Inc. (RGEN)|RNA: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti CRSP (crisprtx.com)|GeneDx (WGS) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati RARE (Ultragenyx Pharmaceutical Inc.)|BEAM (Beam Therapeutics Corp) - PEG multiplikatori|SRPT: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori TWST|PEG multiplikatori 10xgenomics.com (TXG)|Narxning foydaga va o‘sish sur’atiga nisbati Intellia Therapeutics, Inc. NTLA|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti STOK|BLFS - Narxning foydaga va o‘sish sur’atiga nisbati|Wave Pharma (WVE) - Narx-foyda va o‘sish multiplikatori|MAZE: PEG multiplikatori|sionnatx.com (SION) - PEG multiplikatori|PRME (Prime Medicine) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Taysha Gene Therapies Inc (TSHA)|PEG multiplikatori QURE|MGTX - O‘sish sur’atiga tuzatilgan narx-foyda|REGENXBIO Inc. - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori solidbio.com SLDB|OCGN: Narx-foyda va o‘sish multiplikatori|Pacific Biosciences of California, Inc. - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|BNTC: PEG multiplikatori|DSGN - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|RCKT (Rocket Pharmaceuticals) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori 4dmoleculartherapeutics.com (FDMT)|PEG multiplikatori LXEO|PEG multiplikatori korrobio.com (KRRO)|Narxning foydaga va o‘sish sur’atiga nisbati Editas EDIT|Silence Therapeutics Corp - Narxning foydaga va o‘sish sur’atiga nisbati|PRQR - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Codexis, Inc. CDXS|SGMO: PEG multiplikatori|NAUT - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Metagenomi, Inc|O‘sish sur’atiga tuzatilgan narx-foyda Precision BioSciences Inc. DTIL|Narxning foydaga va o‘sish sur’atiga nisbati Generation Bio Co. (GBIO)|boundlessbio.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Exicure XCUR|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Imunon Inc (IMNN)|RXi Pharmaceuticals - PEG multiplikatori|MBIO (Mustang Bio, Inc.) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|transcodetherapeutics.com (RNAZ) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti BNGO|APDN (Applied DNA Sciences, Inc.) - PEG multiplikatori|PEG multiplikatori bluebird bio Inc.|PEG multiplikatori IPA|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Omega Therapeutics Corp|Narxning foydaga va o‘sish sur’atiga nisbati Singular Genomics Systems OMIC|regulusrx.com (RGLS) - O‘sish sur’atiga tuzatilgan narx-foyda|SYRS - Narxning foydaga va o‘sish sur’atiga nisbati|TBIO (Telesis Bio Inc.) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|TCON: PEG multiplikatori|UBX - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
